Ixempra Kit
Product Images NDC 70020-1910

Product Visual Gallery

This gallery contains 8 technical images submitted to the FDA as part of the official labeling for Ixempra (NDC 70020-1910). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by R-pharm Us Operating, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Structural Formula (Ixe00 0000 01)

Chemical structure of the active ingredient ixabepilone as depicted in the image, showing its molecular framework consistent with the drug IXEMPRA used in intravenous administration.*

FDA Label Image

Figure 1 (Ixe00 0000 02)

A Kaplan-Meier survival curve comparing the proportion not progressed over time (in months) between two treatment groups: ixabepilone plus capecitabine versus capecitabine alone. The graph shows a trend favoring the combination therapy with stratified logrank p-value < 0.0001.*

FDA Label Image

Ixe00 0000 03 2

Carton label for IXEMPRA Kit (ixabepilone) for injection 15 mg, an intravenous infusion kit by R-Pharm US Operating, LLC. The carton contains single-dose vials including 1 vial of IXEMPRA (15 mg ixabepilone) and 1 vial of diluent (8 mL). It includes storage instructions to refrigerate at 2° to 8°C and a warning that reconstitution and dilution are required. Made in Germany.*

FDA Label Image

Ixe00 0000 04 2

IXEMPRA Kit (ixabepilone) for injection 45 mg carton packaging label. It is for intravenous infusion only, containing one vial of IXEMPRA (ixabepilone) 45 mg and one vial of diluent 23.5 mL. The product is labeled Rx only and distributed by R-Pharm US LLC, Princeton, NJ. The label emphasizes refrigeration and states that reconstitution and dilution are required.*

FDA Label Image

Ixe00 0000 05 2

Label for IXEMPRA (ixabepilone) 15 mg single dose vial for intravenous injection. The label states it is for intravenous infusion only, requires reconstitution and dilution, and is distributed by R-Pharm US LLC. Storage instructions include refrigeration and protection from light. The label also indicates the product is made in Germany and marked as a hazardous drug.*

FDA Label Image

Ixe00 0000 06 2

Label for IXEMPRA 45 mg injection (ixabepilone) kit for intravenous infusion, distributed by R-Pharm US LLC. The label includes storage instructions (refrigerate at 2° to 8°C, protect from light), dosing notes about reconstitution and dilution, and a warning that it is a hazardous drug. The product is made in Germany.*

FDA Label Image

Ixe00 0000 07 2

Label for a single dose vial of DILUENT for IXEMPRA (ixabepilone) injection, 8 mL. The label states it is for intravenous use only and not for direct administration. It includes storage instructions to refrigerate at 2° to 8° C and protect from light. The product is distributed by R-Pharm US LLC in Princeton, NJ, and made in Germany.*

FDA Label Image

Ixe00 0000 08 2

Label for a single dose vial diluent for IXEMPRA (ixabepilone) injection, 23.5 mL. The diluent contains polyoxyethylated castor oil (52.8% w/v) and dehydrated alcohol (39.8% w/v) and is for dilution only. Instructions note refrigeration at 2° to 8° C and protection from light. Distributed by R-Pharm US LLC, Princeton, NJ, made in Germany.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.